Nurix Stock Buy Hold or Sell Recommendation


USD 11.71  0.36  3.17%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Nurix Therapeutics is 'Cautious Hold'. Macroaxis provides Nurix Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NRIX positions. The advice algorithm takes into account all of Nurix Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Nurix Therapeutics' buy-and-hold perspective. Additionally, see Nurix Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Nurix and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Nurix Therapeutics.

Execute Nurix Therapeutics Buy or Sell Advice

The Nurix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nurix Therapeutics. Macroaxis does not own or have any residual interests in Nurix Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nurix Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Nurix TherapeuticsBuy Nurix Therapeutics
Cautious Hold



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Reporting Quality (M-Score)

For the selected time horizon Nurix Therapeutics has a Mean Deviation of 3.08, Standard Deviation of 4.16 and Variance of 17.28
Our investment recommendation tool can cross-verify current analyst consensus on Nurix Therapeutics and to analyze the entity potential to grow in the current economic cycle. To make sure Nurix Therapeutics is not overpriced, please verify all Nurix Therapeutics fundamentals, including its cash and equivalents, as well as the relationship between the cash flow from operations and z score . Given that Nurix Therapeutics has a shares owned by institutions of 101.45 %, we recommend you to check Nurix Therapeutics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Nurix Therapeutics Trading Alerts and Improvement Suggestions

Nurix Therapeutics generated a negative expected return over the last 90 days
Nurix Therapeutics has high historical volatility and very poor performance
The company reported the previous year's revenue of 39.24 M. Net Loss for the year was (171.34 M) with loss before overhead, payroll, taxes, and interest of (86.68 M).
Nurix Therapeutics currently holds about 344.48 M in cash with (152.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.31.
Latest headline from Nurix Announces Initial NX-1607 Phase 1 Data Presented at the 37th Annual Meeting of the Society for Immunotherapy of Cancer Demonstrating Targeted CBL-B Inhibition in Patients with Advanced Malignancies -

Nurix Therapeutics current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nurix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nurix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price34.91
Target Median Price37.00
Target High Price53.00
Recommendation Mean1.80
Number Of Analyst Opinions11
Target Low Price11.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Nurix Therapeutics Returns Distribution Density

The distribution of Nurix Therapeutics' historical returns is an attempt to chart the uncertainty of Nurix Therapeutics' future price movements. The chart of the probability distribution of Nurix Therapeutics stock daily returns describes the distribution of returns around its average expected value. We use Nurix Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nurix Therapeutics returns is essential to provide solid investment advice for Nurix Therapeutics.
Mean Return-0.33Value At Risk-6.49
Potential Upside6.08Standard Deviation4.16
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nurix Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Nurix Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nurix Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nurix Therapeutics backward and forwards among themselves. Nurix Therapeutics' institutional investor refers to the entity that pools money to purchase Nurix Therapeutics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.1 K65 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.1 K72 K
Zurcher Kantonalbank Zurich CantonalbankCommon SharesK117 K
Woodline Partners LpCommon Shares219.3 K3.1 M
Woodline Partners LpCommon Shares592.9 K17.2 M
Woodline Partners LpCommon Shares137.4 K4.1 M
Woodline Partners LpCommon Shares161.2 K5.3 M
Note, although Nurix Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nurix Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nurix Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nurix Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nurix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW1.83
Overall volatility
Information ratio -0.1

Nurix Therapeutics Volatility Alert

Nurix Therapeutics exhibits very low volatility with skewness of 0.34 and kurtosis of 1.71. However, we advise investors to further study Nurix Therapeutics technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nurix Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nurix Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Nurix Therapeutics Fundamentals Vs Peers

Comparing Nurix Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nurix Therapeutics' direct or indirect competition across all of the common fundamentals between Nurix Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nurix Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nurix Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Nurix Therapeutics by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Nurix Therapeutics to competition
FundamentalsNurix TherapeuticsPeer Average
Return On Equity(47.74) %(0.31) %
Return On Asset(22.72) %(0.14) %
Operating Margin(441.21) %(5.51) %
Current Valuation244.91 M16.62 B
Shares Outstanding44.61 M571.82 M
Shares Owned by Insiders3.32 %10.09 %
Shares Owned by Institutions101.45 %39.21 %
Number of Shares Shorted4.97 M4.71 M
Price to Book1.41 X9.51 X
Price to Sales13.52 X11.42 X
Revenue39.24 M9.43 B
Gross Profit(86.68 M)27.38 B
EBITDA(168.64 M)3.9 B
Net Income(171.34 M)570.98 M
Cash and Equivalents344.48 M2.7 B
Cash per Share7.31 X5.01 X
Total Debt13.24 M5.32 B
Debt to Equity0.038 %48.70 %
Current Ratio5.26 X2.16 X
Book Value Per Share8.42 X1.93 K
Cash Flow from Operations(152.76 M)971.22 M
Short Ratio10.92 X4.00 X
Earnings Per Share(2.40) X3.12 X
Number of Employees24218.84 K
Market Capitalization530.44 M19.03 B
Z Score24.08.72
   Exercise or conversion by Van Houte Hans of 2886 shares of Nurix Therapeutics subject to Rule 16b-3 [view details]

About Nurix Therapeutics Buy or Sell Advice

When is the right time to buy or sell Nurix Therapeutics? Buying financial instruments such as Nurix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Nurix Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Military Industrial Thematic Idea Now

Military Industrial
Military Industrial Theme
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
View All  Next Launch
Additionally, see Nurix Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running Nurix Therapeutics price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is Nurix Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix Therapeutics. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
535.1 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Nurix Therapeutics is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Nurix Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix Therapeutics' market value can be influenced by many factors that don't directly affect Nurix Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Nurix Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.